We operate worldwide providing the highest quality stand-alone and integrated drug discovery solutions, covering all activities from target-to-clinic. The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuroscience, pain, metabolic diseases as well as oncology and inflammation. Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, CHDI, Genentech, Janssen Pharmaceuticals, MedImmune/AstraZeneca and Ono Pharmaceutical.

Hamburg, DE
Size (employees)
1,017 (est)
Evotec was founded in 1993 and is headquartered in Hamburg, DE

Key People at Evotec

Werner Lanthaler

Werner Lanthaler

Colin Bond

Colin Bond

Mario Polywka

Mario Polywka

Cord Dohrmann

Cord Dohrmann


Evotec Office Locations

Evotec has offices in Hamburg, South San Francisco, Branford, Princeton and in 5 other locations
Hamburg, DE
Milton, GB
Manchester, GB
Planegg, DE
Toulouse, FR
Göttingen, DE
Princeton, US
Branford, US
South San Francisco, US

Evotec Metrics

Evotec Summary

Market capitalization

€1.1 b

Closing share price

Evotec's current market capitalization is €1.1 b.

Evotec Market Value History

Evotec Online Presence

Evotec Company Life

You may also be interested in